Associate Director Denver Health & Hospital Authority Denver, Colorado
The use of psychedelics such as ketamine and psilocybin is proliferating amid many social, policy, and scientific developments. The goal of this session is to highlight a number of surveillance tools deployed by Rocky Mountain Poison & Drug Services to track trends in benefits and harms of psychedelics from various angles. Attendees will gain insight into this (re)emerging class of substances, better contextualizing trends in acute and chronic harms as well as potential therapeutic uses, including for substance use disorders.
Learning Objectives:
Learners will be able to:
Distinguish between the approach of Colorado’s Natural Medicine Act and common approaches to cannabis legalization.
List 2 different methods of obtaining surveillance data of psychedelics.
Describe 2 national trends in use of psychedelic substances.
Disclosure(s):
Dale J. Terasaki, MD, MPH: No financial relationships to disclose
Andrew A. Monte, MD, PhD: Anebulo: Consultant/Advisory Board (Ongoing)
